Find similar content

Source channel @githubtrending · Post #15024 · Aug 2

#java#adversary_emulation#adversary_exposure_validation#aev#attack_simulation#breach_simulator#cybersecurity#purple_team OpenBAS is a free, open-source platform that helps you plan and run cyberattack simulations to find security weaknesses in your organization. It supports teamwork, real-time monitoring, and detailed feedback, letting you test defenses against real-world threats using up-to-date intelligence from OpenCTI. You can simulate attacks through emails, SMS, social media, and more, making your training realistic and comprehensive. OpenBAS offers both a Community Edition and a more advanced Enterprise Edition. It’s easy to install with Docker or manually, and you can try it online before using it. This helps you improve your cybersecurity by practicing and identifying gaps before real attacks happen. https://github.com/OpenBAS-Platform/openbas

Hashtags

#java #adversary_emulation #adversary_exposure_validation #aev #attack_simulation #breach_simulator #cybersecurity #purple_team

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment